ZA202211247B - Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid - Google Patents

Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid

Info

Publication number
ZA202211247B
ZA202211247B ZA2022/11247A ZA202211247A ZA202211247B ZA 202211247 B ZA202211247 B ZA 202211247B ZA 2022/11247 A ZA2022/11247 A ZA 2022/11247A ZA 202211247 A ZA202211247 A ZA 202211247A ZA 202211247 B ZA202211247 B ZA 202211247B
Authority
ZA
South Africa
Prior art keywords
cocrystals
ylcarbamoyl
thiazol
cyano
phenyl
Prior art date
Application number
ZA2022/11247A
Other languages
English (en)
Inventor
Castro Palomino Laria Julio
Camacho Gómez Juan
Original Assignee
Palobiofarma Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palobiofarma Sl filed Critical Palobiofarma Sl
Publication of ZA202211247B publication Critical patent/ZA202211247B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/02—Salts; Complexes; Addition compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA2022/11247A 2020-03-16 2022-10-13 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid ZA202211247B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20382194.7A EP3882240A1 (en) 2020-03-16 2020-03-16 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid
PCT/EP2021/056506 WO2021185748A1 (en) 2020-03-16 2021-03-15 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid

Publications (1)

Publication Number Publication Date
ZA202211247B true ZA202211247B (en) 2023-12-20

Family

ID=69953938

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/11247A ZA202211247B (en) 2020-03-16 2022-10-13 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid

Country Status (21)

Country Link
US (1) US12384754B2 (cg-RX-API-DMAC10.html)
EP (2) EP3882240A1 (cg-RX-API-DMAC10.html)
JP (1) JP7779846B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220154791A (cg-RX-API-DMAC10.html)
CN (1) CN115298169B (cg-RX-API-DMAC10.html)
AU (1) AU2021237686B2 (cg-RX-API-DMAC10.html)
BR (1) BR112022018449A2 (cg-RX-API-DMAC10.html)
CA (1) CA3171894C (cg-RX-API-DMAC10.html)
DK (1) DK4121419T3 (cg-RX-API-DMAC10.html)
ES (1) ES3002084T3 (cg-RX-API-DMAC10.html)
FI (1) FI4121419T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20241515T1 (cg-RX-API-DMAC10.html)
HU (1) HUE068886T2 (cg-RX-API-DMAC10.html)
LT (1) LT4121419T (cg-RX-API-DMAC10.html)
MX (1) MX2022011530A (cg-RX-API-DMAC10.html)
PL (1) PL4121419T3 (cg-RX-API-DMAC10.html)
PT (1) PT4121419T (cg-RX-API-DMAC10.html)
RS (1) RS66214B1 (cg-RX-API-DMAC10.html)
SI (1) SI4121419T1 (cg-RX-API-DMAC10.html)
WO (1) WO2021185748A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202211247B (cg-RX-API-DMAC10.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2331220B1 (es) * 2007-10-02 2010-09-23 Palobiofarma, S.L. Nuevos compuestos como antagonistas de los receptores a1 de adenosina.
WO2011158110A2 (en) 2010-04-28 2011-12-22 Nuformix Limited Cilostazol cocrystals and compositions
LT3592734T (lt) 2017-03-06 2021-07-26 Palobiofarma, S.L. (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksirūgšties amino druska

Also Published As

Publication number Publication date
PT4121419T (pt) 2024-11-18
KR20220154791A (ko) 2022-11-22
EP3882240A1 (en) 2021-09-22
EP4121419B1 (en) 2024-08-14
ES3002084T3 (en) 2025-03-06
HRP20241515T1 (hr) 2025-01-03
HUE068886T2 (hu) 2025-02-28
SI4121419T1 (sl) 2025-02-28
WO2021185748A1 (en) 2021-09-23
LT4121419T (lt) 2024-11-25
RS66214B1 (sr) 2024-12-31
CN115298169B (zh) 2024-11-19
CN115298169A (zh) 2022-11-04
JP7779846B2 (ja) 2025-12-03
US20230183195A1 (en) 2023-06-15
CA3171894A1 (en) 2021-09-23
AU2021237686A1 (en) 2022-10-06
BR112022018449A2 (pt) 2022-11-01
DK4121419T3 (da) 2024-10-28
US12384754B2 (en) 2025-08-12
AU2021237686B2 (en) 2026-04-09
PL4121419T3 (pl) 2025-02-17
FI4121419T3 (fi) 2024-11-04
CA3171894C (en) 2025-03-11
JP2023517722A (ja) 2023-04-26
MX2022011530A (es) 2022-10-13
EP4121419A1 (en) 2023-01-25

Similar Documents

Publication Publication Date Title
AU2015293541B2 (en) Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof
EP4003950A4 (en) C4 ALKANOIC ACID RECYCLING CONTENT
EP3891620A4 (en) TRANSACTIONAL STREAMING OF CHANGE TRACKING DATA
EP3956783A4 (en) MONETIZATION OF ANIMAL DATA
EP4212503A4 (en) FLUORINATED CARBOXYLIC ACID SALT COMPOUND
SI4121419T1 (sl) Kokristali (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentan karboksilne kisline
HK40087530A (en) Cocrystals of(1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid
CA3287816A1 (en) Method for the compression of genome sequence data
PL3592734T3 (pl) Sól aminowa kwasu (1r,3s)-3-(5-cyano-4-fenylo-1,3-tiazol- 2-ilokarbamoilo)cyklopentanokarboksylowego
EP4059944A4 (en) METHOD FOR PREPARING AN OLIGONUCLICE ACID COMPOUND
EP4059943A4 (en) METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND
EP4083224A4 (en) METHOD FOR ASYMMETRIC TARGET NUCLEIC ACID AMPLIFICATION
EP3922728A4 (en) PROCESS FOR THE PREPARATION OF (1R ,3R)-3-(TRIFLUORMETHYL)CYCLOHEXAN-1-OL AND INTERMEDIATE THEREOF
EP3976110A4 (en) DRUG TARGET OF IDIOPATHIC PULMONARY FIBROSIS
IL288874A (en) [((5r,2s,1r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-isopropyl acetic acid ester for the treatment of chronic cough
EP4319743A4 (en) UPADACITINIB CO-CRYSTALS
HUP2200363A1 (hu) Eljárás (1r,4r)-4-helyettesített ciklohexán-1-aminok elõállítására
IL290505A (en) Process for the preparation of carboxylic acid derivatives of 3-bromo-4,5-dihydro-1h-pyrazoles
EP3093281A4 (en) Alkali metal salt of perfluoro(vinyloxy polyether) carboxylic acid, and method for producing same
HK40128362A (en) Metap2 inhibitors for the treatment of pulmonary fibrosis
CA3264343A1 (en) METAP2 INHIBITORS FOR THE TREATMENT OF PULMONARY FIBROSIS
HK40116338A (en) Crystalline forms of n-((1r,3s)-3-(4-acetylpiperazin-1-yl)cyclohexyl)-4-fluoro-7-methyl-1h-indole-2-carboxamide
CA3287358A1 (en) Formation of co-crystals
HK40073337A (en) Glycolate oxidase inhibitors for the treatment of disease
HK40058379A (en) Methods of promoting remyelination